Asmi Chakraborty

Asmi Chakraborty is a Fellow at Breakout Ventures and a Translational Scientist at Palleon Pharmaceuticals. They are also a Venture Team Co-Founder at Harvard Innovation Labs. Previously, Asmi held positions such as Postdoctoral Fellow at Harvard Medical School, PhRMA Foundation Translational Medicine Fellow, and Project Advisor at Careers Infinite. Asmi's research focuses on dissecting the role of glycosylation in Pancreatic Ductal Adenocarcinoma (PDAC) initiation and progression. With a background in Cancer Biology and extensive postdoctoral training, Asmi is a valuable asset in the field of translational medicine.